Table of Contents Author Guidelines Submit a Manuscript
Journal of Cancer Epidemiology
Volume 2016 (2016), Article ID 8784040, 5 pages
Research Article

Breast Cancer Prevalence and Mortality among Hispanic Subgroups in the United States, 2009–2013

Sinai Urban Health Institute, Sinai Health System, 1500 South Fairfield Avenue, Chicago, IL 60608-1797, USA

Received 2 February 2016; Revised 28 April 2016; Accepted 8 May 2016

Academic Editor: Lidia Larizza

Copyright © 2016 Bijou R. Hunt. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. This paper presents data on breast cancer prevalence and mortality among US Hispanics and Hispanic subgroups, including Cuban, Mexican, Puerto Rican, Central American, and South American. Methods. Five-year average annual female breast cancer prevalence and mortality rates for 2009–2013 were examined using data from the National Health Interview Survey (prevalence) and the National Center for Health Statistics and the American Community Survey (mortality rates). Results. Overall breast cancer prevalence among US Hispanic women was 1.03%. Although the estimates varied slightly by Hispanic subgroup, these differences were not statistically significant. The breast cancer mortality rate for Hispanics overall was 17.71 per 100,000 women. Higher rates were observed among Cubans (17.89), Mexicans (18.78), and Puerto Ricans (19.04), and a lower rate was observed among Central and South Americans (10.15). With the exception of the rate for Cubans, all Hispanic subgroup rates were statistically significantly different from the overall Hispanic rate. Additionally, all Hispanic subgroups rates were statistically significantly higher than the Central and South American rate. Conclusion. The data reveal significant differences in mortality across Hispanic subgroups. These data enable public health officials to develop targeted interventions to help lower breast cancer mortality among the highest risk populations.